GenSci122

· Changchun GeneScience Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GenSci122, covering 2025-01-22 to 2025-01-22. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Investigate Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy With GenSci122 in Participants With Advanced Solid Tumors [Phase 1]

See pricing